February 6, 2026

iRadimed Corporation (IRMD): Investor Outlook Reveals Nearly 5% Upside Potential

iRadimed Corporation (NASDAQ: IRMD) has been making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $1.2 billion, the..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking a 78% Potential Upside Amid Healthcare Innovations

Investors keen on the healthcare sector might find Relay Therapeutics, Inc. (NASDAQ: RLAY) a compelling story, given its significant potential upside and innovative approach in biotechnology...

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Healthcare Star with a 208% Potential Upside

Niagen Bioscience, Inc. (NAGE), a prominent player in the biotechnology sector, is attracting significant attention with its compelling investment potential. Headquartered in Los Angeles, California, Niagen..

Enhabit, Inc. (EHAB) Stock Analysis: Unlocking a 6.62% Potential Upside in the Healthcare Sector

Enhabit, Inc. (EHAB), a significant player in the healthcare sector, has caught the attention of investors looking to capitalize on the growing demand for medical care..

Enliven Therapeutics, Inc. (ELVN): Investor Outlook with a 53.3% Potential Upside and Strong Buy Ratings

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of savvy investors in the biotechnology sector. With a market capitalization of $1.6 billion, this clinical-stage biopharmaceutical..

Zymeworks Inc. (ZYME) Stock Analysis: Biotech’s 61.74% Upside Potential Amid Robust Revenue Growth

Investors eyeing opportunities in the biotechnology sector should take a closer look at Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage company making strides in the realm of..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A 145% Upside Amidst Innovative Biotech Ventures

Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing significant interest in the biotechnology sector, with a compelling potential upside of 145.47% based on current analyst targets. This..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing a Potential 53% Upside in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking opportunities in a..

HealthStream, Inc. (HSTM) Stock Analysis: Unlocking a 60% Upside Potential

HealthStream, Inc. (NASDAQ: HSTM), a leading provider in the health information services sector, offers an intriguing investment opportunity as it stands poised for significant growth. With..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (OMI), a key player in the healthcare sector, is drawing attention from investors due to its significant upside potential, pegged at 94.29%...

Replimune Group, Inc. (REPL) Stock Analysis: Exploring an 85% Potential Upside in the Biotech Sector

Investors eyeing the biotechnology sector for promising opportunities might find Replimune Group, Inc. (NASDAQ: REPL) a compelling case, especially given its impressive potential upside of 85.53%..

Cogent Biosciences, Inc. (COGT) Investor Outlook: 42% Potential Upside Drives Interest in Biotech Innovator

Investors with an eye on the biotechnology sector may find Cogent Biosciences, Inc. (NASDAQ: COGT) a compelling opportunity. With a market capitalization of $5.48 billion, this..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech Company with Over 100% Potential Upside

Investors seeking opportunities in the biotechnology sector might find CorMedix Inc. (NASDAQ: CRMD) an intriguing candidate. With a current market capitalization of $579.1 million, this healthcare..

GH Research PLC (GHRS) Stock Analysis: A Biotech Pioneer with a 146.95% Upside Potential

GH Research PLC (NASDAQ: GHRS), an emerging player in the biotechnology sector, has garnered significant attention from the investment community, primarily due to its promising drug..

Delcath Systems, Inc. (DCTH) Investor Outlook: Analyzing a 149.81% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its robust potential upside of..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Exploring a 37% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK) has captured the attention of investors with its distinctive approach to treating severe genetic diseases. As a pioneering entity in the..

Altimmune, Inc. (ALT) Investor Outlook: Huge 259% Upside Potential as Analysts Bet Big on Biotech Breakthrough

For investors eyeing opportunities in the dynamic healthcare sector, Altimmune, Inc. (NASDAQ: ALT) presents a compelling case with its robust potential upside of 259.08%. This Gaithersburg,..

Arvinas, Inc. (ARVN) Stock Analysis: Navigating Potential Amidst Biotechnology Challenges

Arvinas, Inc. (NASDAQ: ARVN) is an intriguing company within the biotechnology sector, known for its innovative approach to drug development. With a market capitalization of approximately..

Auna SA (AUNA) Stock Analysis: 77% Potential Upside Captures Investor Attention

Auna SA (AUNA), a healthcare service provider with a significant footprint in Latin America, is garnering attention from investors due to its impressive potential upside of..

Amylyx Pharmaceuticals, Inc. (AMLX): Investor Outlook with 55.68% Potential Upside

Amylyx Pharmaceuticals, Inc. (AMLX), a clinical-stage pharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the healthcare sector with its innovative approach to treating neurodegenerative..

Search

Funds

February 6, 2026

Search

Funds

February 6, 2026

FTSE 100

Funds